1. Home
  2. ALKS vs PAM Comparison

ALKS vs PAM Comparison

Compare ALKS & PAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALKS
  • PAM
  • Stock Information
  • Founded
  • ALKS 1987
  • PAM 1945
  • Country
  • ALKS Ireland
  • PAM Argentina
  • Employees
  • ALKS N/A
  • PAM N/A
  • Industry
  • ALKS Biotechnology: Pharmaceutical Preparations
  • PAM Electric Utilities: Central
  • Sector
  • ALKS Health Care
  • PAM Utilities
  • Exchange
  • ALKS Nasdaq
  • PAM Nasdaq
  • Market Cap
  • ALKS 5.4B
  • PAM 4.5B
  • IPO Year
  • ALKS 1991
  • PAM N/A
  • Fundamental
  • Price
  • ALKS $33.02
  • PAM $77.30
  • Analyst Decision
  • ALKS Buy
  • PAM Buy
  • Analyst Count
  • ALKS 13
  • PAM 4
  • Target Price
  • ALKS $39.50
  • PAM $67.38
  • AVG Volume (30 Days)
  • ALKS 1.7M
  • PAM 178.7K
  • Earning Date
  • ALKS 04-30-2025
  • PAM 03-05-2025
  • Dividend Yield
  • ALKS N/A
  • PAM N/A
  • EPS Growth
  • ALKS 3.47
  • PAM 1544.28
  • EPS
  • ALKS 2.17
  • PAM 0.40
  • Revenue
  • ALKS $1,557,632,000.00
  • PAM $1,680,796,133.00
  • Revenue This Year
  • ALKS N/A
  • PAM $39.25
  • Revenue Next Year
  • ALKS $4.37
  • PAM $37.99
  • P/E Ratio
  • ALKS $15.10
  • PAM $9.61
  • Revenue Growth
  • ALKS N/A
  • PAM 237.32
  • 52 Week Low
  • ALKS $22.90
  • PAM $38.58
  • 52 Week High
  • ALKS $36.45
  • PAM $97.55
  • Technical
  • Relative Strength Index (RSI)
  • ALKS 42.12
  • PAM 44.60
  • Support Level
  • ALKS $33.22
  • PAM $78.31
  • Resistance Level
  • ALKS $34.45
  • PAM $84.81
  • Average True Range (ATR)
  • ALKS 0.96
  • PAM 3.29
  • MACD
  • ALKS -0.23
  • PAM 0.09
  • Stochastic Oscillator
  • ALKS 28.87
  • PAM 23.05

About ALKS Alkermes plc

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.

About PAM Pampa Energia S.A.

Pampa Energia SA and its subsidiaries are engaged in the Energy business. The operating business segments of the firm are Electricity generation, Electricity distribution, Oil and Gas, Petrochemicals, and Holding and other business. The company derives the maximum revenue from the Distribution of energy.

Share on Social Networks: